Herein, we characterize two novel EGFR ECD mutations that are concurrently selected for in patient-derived HNSCC cells while these cells were repeatedly exposed to CTX in an effort to mimic what may occur clinically. This evidence concerns the gene EGFR and head and neck squamous cell carcinoma.